Infected cerebrospinal fluid shunts.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000209:etiology*; D001812:Blood-Brain Barrier; D002512:Cephalothin / Q000627:therapeutic use; D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects*; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D004165:Diphtheria / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D006849:Hydrocephalus / Q000601:surgery; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008712:Methicillin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology; D013290:Streptococcal Infections / Q000188:drug therapy / Q000209:etiology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D002701:Chloramphenicol; D000667:Ampicillin; D008712:Methicillin; D002512:Cephalothin